Amplia Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is April - March.

Millions AUD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Mar '26 Mar 6, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2020 - 2016
Market Capitalization	56	27	15	16	28	28	Upgrade
Market Cap Growth	73.19%	81.79%	-9.41%	-41.33%	0.13%	628.25%	Upgrade
Enterprise Value	28	23	12	7	25	24	Upgrade
Last Close Price	0.11	0.07	0.07	0.08	0.14	0.25	Upgrade
PS Ratio	11.27	7.18	3.36	13.86	14.17	18.31	Upgrade
PB Ratio	1.31	1.29	1.31	1.04	1.29	2.72	Upgrade
P/TBV Ratio	1.61	2.08	4.29	2.09	2.02	11.69	Upgrade
EV/Sales Ratio	5.52	5.99	2.59	5.99	12.57	15.85	Upgrade
Debt / Equity Ratio	0.01	0.00	0.14	0.14	0.10	-	Upgrade
Net Debt / Equity Ratio	-0.67	-0.52	-0.16	-0.44	-0.57	-0.18	Upgrade
Net Debt / EBITDA Ratio	3.46	1.60	0.39	1.11	3.44	0.79	Upgrade
Net Debt / FCF Ratio	2.15	1.58	0.35	1.32	2.83	0.63	Upgrade
Asset Turnover	0.17	0.20	0.27	0.06	0.11	0.15	Upgrade
Quick Ratio	27.76	7.75	1.93	3.78	31.03	5.28	Upgrade
Current Ratio	28.17	7.91	1.98	3.82	31.18	5.45	Upgrade
Return on Equity (ROE)	-28.49%	-40.51%	-33.05%	-33.13%	-22.64%	-24.08%	Upgrade
Return on Assets (ROA)	-17.71%	-22.47%	-17.04%	-18.20%	-12.88%	-14.63%	Upgrade
Return on Capital Employed (ROCE)	-19.20%	-32.30%	-39.90%	-39.40%	-15.20%	-22.60%	Upgrade
Earnings Yield	-14.06%	-24.20%	-30.15%	-37.85%	-12.96%	-8.13%	Upgrade
FCF Yield	-23.72%	-25.36%	-34.34%	-32.18%	-15.71%	-10.41%	Upgrade
Buyback Yield / Dilution	-75.83%	-58.35%	-0.02%	-33.27%	-53.71%	-95.36%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.